News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025
Meril Life Sciences presents one-year outcomes from the LANDMARK Randomized Controlled Trial at PCR London Valves 2025, comparing THV series in aortic stenosis patients. Study highlights Myval THV series performance in clinical efficacy and patient safety -
-
-
-
-
COMMUNIQUÉ DE PRESSE
LEPAS L8 Elevates Every Family Journey with Elegant Driving and Exquisite Space
LEPAS introduces the new L8 model, providing elegant driving and exquisite space for family journeys. Features include spacious interior, entertainment options, and advanced technology for comfort and convenience